Celyad Oncology

Rue Edouard Belin 12
1435 Mont-Saint-Guibert
BE
Celyad Oncology
Foundation date
24/07/2007
Sector
#Biotechnology - TherapeuticsSubsector
Therapeutic areas
Celyad Oncology is a clinical-stage biotechnology company focused on the discovery and development of CAR T therapies for cancer. The Company is developing a pipeline of allogeneic (off-the-shelf) and autologous (personalized) CAR T cell therapy candidates for the treatment of both hematological malignancies and solid tumors. Celyad Oncology was founded in 2007 and is based in Mont-Saint-Guibert, Belgium and New York, NY. The Company has received funding from the Walloon Region (Belgium) to support the advancement of its CAR T cell therapy programs. For more information, please visit www.celyad.com.
Upcoming events
All events-
0106 '23
KNOWLEDGE FOR GROWTH 2023
Event by: flanders.bio -
0506 '23
BIO International Convention 2023
Event by: Biotechnology Innovation Organisation -
2206 '23
Translational Research in Crops
Event by: VIB
Latest news
More news-
Mithra appoints experienced life sciences executive Christian Homsy* as Chairman
1 day ago
Read more
-
Oxurion reaches enrollment target in KALAHARI Phase 2, Part B trial of novel PKal inhibitor THR-149 in diabetic macular edema
Friday May 26th 2023
Read more
-
How garbage disposal clogs in cells can lead to Alzheimer’s
Friday May 26th 2023
Read more
Jobs
More jobs-
31/05/23
Flemish Brabant
Postdoc Position on the Bioinformatics of Spatial Transcriptomics in Alzheimer’s Disease
Permanent
VIB -
30/05/23
Remote, Brussels, Abroad
Executive, Chief Financial Officer - European Operations
Permanent, Freelance
General Inception -